News
WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced ...
Experts and advocates say that twice-a-year HIV PrEP injections have the prevention potential of a vaccine — and that a once-a-year version of lenacapavir would be even better. But will Yeztugo be ...
A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One ...
The Food and Drug Administration has approved a new drug that could prevent HIV infections with just two shots every year and ...
Clinical trials showed 99.9% of participants who received the drug, called Yeztugo from company Gilead Sciences, remained ...
according to money experts FDA approves powerful HIV drug with the potential to end the epidemic in the U.S. You Just Started ...
The Food and Drug Administration has approved lenacapavir, a breakthrough medication that reduces the risk of contracting HIV ...
The FDA has approved Yeztugo, the world’s first twice-a-year HIV prevention shot, proven to stop 99.9% of infections in ...
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results